Research and Markets: Global Scar Pipeline Review H2 2015

Research and Markets (http://www.researchandmarkets.com/research/49vwk7/scar_pipeline) has announced the addition of the "Scar - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Scars, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with the latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Scars and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Companies Mentioned

  • 3M Drug Delivery Systems
  • AlbireoPharma
  • Altacor Limited
  • Beech Tree Labs, Inc.
  • Biokine Therapeutics Ltd.
  • Clanotech AB
  • Critical Outcome Technologies Inc.
  • Derma Sciences, Inc.
  • Easton Pharmaceuticals Inc.
  • EyeGene, Inc.
  • Fibrocell Science, Inc.
  • FirstString Research, Inc.
  • Isarna Therapeutics GmbH
  • Juventas Therapeutics, Inc.
  • LegoChem Biosciences, Inc
  • Moerae Matrix, Inc.
  • Pergamum AB
  • RXi Pharmaceuticals Corporation
  • Symic Biomedical, Inc.
  • VBS Pharmaceuticals

For more information visit http://www.researchandmarkets.com/research/49vwk7/scar_pipeline.

Contacts:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Dermatology

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.